β1 and β3 integrins cooperate to induce syndecan-4-containing cross-linked actin networks in human trabecular meshwork cells

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 5, 2006, Pages 1956-1967

  Filla, Mark S ^a   Woods, Anne ^b   Kaufman, Paul L ^a   Peters, Donna M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIN RELATED PROTEIN 3; ALPHA ACTININ; ALPHA2BETA1 INTEGRIN ANTIBODY; BETA1 INTEGRIN; BETA1 INTEGRIN ANTIBODY; BETA2 INTEGRIN ANTIBODY; BETA3 INTEGRIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CORTACTIN; DEXAMETHASONE; FIBRONECTIN; FILAMIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN ANTIBODY; STEROID; SYNDECAN 4; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VITRONECTIN; ACTIN BINDING PROTEIN; ACTININ; CONTRACTILE PROTEIN; FILAMINS; GLUCOCORTICOID; MEMBRANE PROTEIN; PROTEOGLYCAN; SDC4 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; METABOLISM; MICROFILAMENT; PHYSIOLOGY;

ACTININ; ACTINS; ANTIGENS, CD29; CELL CULTURE TECHNIQUES; CONTRACTILE PROTEINS; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; INTEGRIN BETA3; MEMBRANE GLYCOPROTEINS; MICROFILAMENT PROTEINS; MICROFILAMENTS; MICROSCOPY, FLUORESCENCE; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PROTEOGLYCANS; SIGNAL TRANSDUCTION; SYNDECAN-4; TRABECULAR MESHWORK;

EID: 33744722433     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0626     Document Type: Article

References (88)

1. Hilpela PV, Vartiaininen MK, Lappalainen P. Regulation of the actin cytoskeleton by PI(4,5)P2 and PI(3,4,5)P3. Curr Topics Microbiol Immunol. 2004;282:117-163.
2. Rao PV, Deng PF, Kumar J, Epstein DL. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci. 2001;42:1029-1037.
3. Thieme H, Nuskovski M, Nass JU, et al. Mediation of calcium-independent contraction in trabecular meshwork through protein kinase C and Rho-A. Invest Ophthalmol Vis Sci. 2000;41:4240-4246.
4. Tian B, Geiger B, Epstein DL, Kaufman PL. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci. 2000;41:619-623.
5. Epstein DL, Rowlette L, Roberts BC. Acto-myosin drug effects and aqueous outflow function. Invest Ophthalmol Vis Sci. 1999;40:74-81.
6. Gills JP, Roberts BC, Epstein DL. Microtubule disruption leads to cellular contraction in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1998;39:653-658.
7. Wordinger RJ, Clark AF. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res. 1999;18:629-667.
8. Wilson K, McCartney MD, Miggans ST, Clark AF. Dexamethasone induced ultrastructural changes in cultured human trabecular meshwork cells. Curr Eye Res. 1993;12:783-793.
9. Clark AF, Wilson K, McCartney MD, et al. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1994;35:281-294.
10. Knepper PA, Collins JA, Frederick R. Effects of dexamethasone, progesterone, and testosterone on IOP and GAGs in the rabbit eye. Invest Ophthalmol Vis Sci. 1985;26:1093-1100.
11. Kass M, Cheetham J, Duzman E, Burke PJ. The ocular hypertensive effect of 0.25% fluorometholone in corticosteroid responders. Am J Ophthalmol. 1986;102:159-163.
12. Clark AF, Wilson K, de Kater AW, Allingham RR, McCartney MD. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol Vis Sci. 1995;36:478-489.
13. Gelatt KN, Mackay EO. The ocular hypertensive effects of topical 0.1% dexamethasone in beagles with inherited glaucoma. J Ocular Pharmacol Ther. 1998;14:57-66.
14. Clark AF, Brotchie D, Read AT, et al. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskel. 2005;60:83-95.
15. Clark AF, Lane D, Wilson K, Miggans ST, McCartney MD. Inhibition of dexamethasone-induced cytoskeletal changes in cultured human trabecular meshwork cells by tetrahydrocortisol. Invest Ophthalmol Vis Sci. 1996;37:805-813.
16. Clark AF, Miggans ST, Wilson K, Browder S, McCarthy MD. Cytoskeletal changes in cultured human glaucoma trabecular meshwork cells. J Glaucoma. 1995;4:183-188.
17. Liu X, Wu Z, Sheibani N, et al. Low dose latrunculin-A inhibits dexamethasone-induced changes in the actin cytoskeleton and alters extracellular matrix protein expression in cultured human trabecular meshwork cells. Exp Eye Res. 2003;77:181-188.
18. Gordon WE 3rd, Bushnell A. Immunofluorescent and ultrastructural studies of polygonal microfilament networks in respreading non-muscle cells. Exp Cell Res. 1979;120:335-348.
19. Lazarides E. Actin, α-actinin, and tropomyosin interaction in the structural organization of actin filaments in nonmuscle cells. J Cell Biol. 1976;68:202-219.
20. Sanger JM, Mittal B, Pochapin M, Sanger JW. Observations of microfilament bundles in living cells microinjected with fluorescently labelled contractile proteins. J Cell Sci Suppl. 1986;5:17- 44.
21. Ireland GW, Sanders EJ, Voon FC, Wakely J. The ultrastructure of polygonal networks in chick embryonic cells in vitro. Cell Biol Int. 1983;7:679-688.
22. Mochizuki Y, Furukawa K, Mitaka T, Yokoi T, Kodama T. Polygonal networks, "geodomes", of adult rat hepatocytes in primary culture. Cell Biol Int. 1988;12:1-7.
23. Ireland GW, Voon FC. Polygonal networks in living chick embryonic cells. J Cell Sci. 1981;52:55-69.
24. Lin ZX, Holtzer S, Schultheiss T, et al. Polygons and adhesion plaques and the disassembly and assembly of myofibrils in cardiac myocytes. J Cell Biol. 1989;108:2355-2367.
25. Wang N, Butler JP, Ingber DE. Mechanotransduction across the cell surface and through the cytoskeleton. Science. 1993;260:1124-1127.
26. Burridge K, Wennerberg K. Rho and Rac take center stage. Cell. 2004;116:167-179.
27. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028-1032.
28. Brakebusch C, Fassler R. The integrin-actin connection, an eternal love affair. EMBO J. 2003;22:2324-2333.
29. Couchman JR, Woods A. Syndecan-4 and integrins: combinatorial signaling in cell adhesion. J Cell Sci. 1999;112:3415-3420.
30. Couchman JR, Chen L, Woods A. Syndecans and cell adhesion. Int Rev Cytol. 2001;207:113-150.
31. Beauvais DM, Rapraeger AC. Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol. 2004;2:3.
32. Filla MS, David G, Weinreb RN, Kaufman PL, Peters DP. Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix associated syndecan-2. Exp Eye Res. 2004;79:61-74.
33. Polansky JR, Weinreb RN, Baxter JD, Alvarado J. Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci. 1979;18:1043-1049.
34. Polansky JR, Weinreb R, Alvarado JA. Studies on human trabecular cells propagated in vitro. Vis Res. 1981;21:155-160.
35. Filla MS, Lui X, Nguyen TD, et al. In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin. Invest Ophthalmol Vis Sci. 2002;43:151-161.
36. Maddala R, Reddy VN, Epstein DL, Rao V. Growth factor induced activation of Rho and Rac GTPases and actin cytoskeletal reorganization in human lens epithelial cells. Mol Vis. 2003;9:329-336.
37. Mosesson MW, Umfleet RA. The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components. J Cell Sci. 1970;245:5728-5736.
38. Steele JG, Johnson G, Underwood PA. Role of serum vitronectin and fibronectin in adhesion of fibroblasts following seeding onto tissue culture polystyrene. J Biomed Mater Res. 1992;26:861-884.
39. Suzuki S, Oldberg A, Hayman EG, Pierschbacher MD, Ruoslahti E. Complete amino acid sequence of human vitronectin deduced from cDNA: similarity of cell attachment sites in vitronectin and fibronectin. EMBO J. 1985;4:2519-2524.
40. Aukhil I, Joshi P, Yan Y, Erickson HP. Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. J Cell Sci. 1993;268:2542-2553.
41. Santas AJ, Peterson JA, Halbleib JL, et al. Alternative splicing of the IIICS domain in fibronectin governs the role of the heparin II domain in fibrillogenesis and cell spreading. J Biol Chem. 2002;277:13650-13658.
42. Longley RL, Woods A, Fleetwood A, et al. Control of morphology, cytoskeleton and migration by syndecan-4. J Cell Sci. 1999;112:3421-3431.
43. Yun AJ, Murphy CG, Polansky JR, Newsome DA, Alvarado JA. Proteins secreted by human trabecular cells: glucocorticoid and other effects. Invest Ophthalmol Vis Sci. 1989;30:2012-2022.
44. Zhou LL, Li YH, Yue B. Glucocorticoid effects on extracellular matrix proteins and integrins in bovine trabecular meshwork cells in relation to glaucoma. Int J Mol Med. 1998;1:339-346.
45. Oh ES, Woods A, Lim ST, Theibert AW, Couchman JR. Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-bisphosphate coordinately regulate protein kinase C activity. J Biol Chem. 1998;273:10624-10629.
46. Saoncella S, Echtermeyer F, Denhez F, et al. Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc Nat Acad Sci USA. 1999;96:2805-2810.
47. Woods A, Couchman JR. Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Mol Biol Cell. 1994;5:183-192.
48. Weaver AM, Young ME, Lee W-L, Cooper JA. Integration of signals to the Arp2/3 complex. Curr Opin Cell Biol. 2003;15:23-30.
49. Wilkins JA, Li A, Ni H, Stunpack DG, Shen C. Control of β1 integrin function: localization of stimulatory epitopes. J Biol Chem. 1996;271:3046-3051.
50. Coppolino M, Leung-Hagesteijn C, Dedhar S, Wilkins J. Inducible interaction of integrin α2β1 with calreticulin: dependence on the activation state of the integrin. J Biol Chem. 1995;270:23132-23138.
51. Schreider C, Peignon G, Thenet S, Chambaz J, Pincon-Raymond M. Integrin-mediated functional polarization of Caco-2 cells through E-cadherin-actin complexes. J Cell Sci. 2002;115:543-552.
52. Ho WC, Heinemann C, Hangan D, et al. Modulation of in vivo migratory function of α2β1 integrin in mouse liver. Mol Biol Cell. 1997;8:1863-1875.
53. Pelletier AJ, Kunicki T, Ruggeri ZM, Quaranta V. The activation state of the integrin αIIbβ3 affects outside-in signals leading to cell spreading and focal adhesion kinase phosphorylation. J Biol Chem. 1995;270:18133-18140.
54. Mould AP, Humphries MJ. Identification of a novel recognition sequence for the integrin alpha 4 beta 1 in the COOH-terminal heparin-binding domain of fibronectin. EMBO J. 1991;10:4089-4095.
55. Peterson JA, Sheibani N, David G, Garcia-Pardo A, Peters DM. Heparin II domain of fibronectin uses α4β1 integrin to control focal adhesion and stress fiber formation, independent of syndecan-4. J Biol Chem. 2005;280:6915-6922.
56. Zhou L, Zhang S, Yue BY. Adhesion of human trabecular meshwork cells to extracellular matrix proteins: Roles and distribution of integrin receptors. Invest Ophthalmol Vis Sci. 1996;37:104-113.
57. Mould AP, Komoriya A, Yamada KM, Humphries MJ. The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin α4β1: inhibition of α4β1 function by RGD peptide homologues. J Biol Chem. 1991;266:3579-3585.
58. Elices MJ, Osborn L, Takada Y, et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 1990;60:577-584.
59. Yue BY. The extracellular matrix and its modulation in the trabecular meshwork. Sur Ophthalmol. 1996;40:379-390.
60. Greene DK, Tumova S, Couchman JR, Woods A. Syndecan-4 associates with α-actinin. J Biol Chem. 2003;278:7617-7623.
61. Cohen AR, Woods DF, Marfatia SM, et al. Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells. J Cell Biol. 1998;142:129-138.
62. Grootjans JJ, Reekmans G, Ceulemans H, David G. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin. J Biol Chem. 2000;275:19933-19941.
63. Granes F, Urena JM, Rocamora N, Vilaro S. Ezrin links syndecan-2 to the cytoskeleton. J Cell Sci. 2000;113:1267-1276.
64. Biederer T, Sudhof TC. CASK and protein 4.1 support F-actin nucleation on neurexins. J Biol Chem. 2001;276:47869-47876.
65. Bass MD, Humphries MJ. Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling. Biochem J. 2002;368:1-15.
66. Oh ES, Woods A, Couchman JR. Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J Biol Chem. 1997;272:11805-11811.
67. Oh ES, Woods A, Couchman JR. Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J Biol Chem. 1997;272:8133-8136.
68. Calderwood DA, Shattil SJ, Ginsberg MH. Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling. J Biol Chem. 2000;275:22607-22610.
69. Keely PJ, Rusyn EV, Cox AD, Parise LV. R-Ras signals through specific integrin alpha cytoplasmic domains to promote migration and invasion of breast epithelial cells. J Cell Biol. 1999;145:1077-1088.
70. Sastry SK, Lakonishok M, Thomas DA, Muschler J, Horwitz AF. Integrin alpha subunit ratios, cytoplasmic domains, and growth factor synergy regulate muscle proliferation and differentiation. J Cell Biol. 1996;133:169-184.
71. Schwartz MA, Denninghoff K. Alpha v integrins mediate the rise in intracellular calcium in endothelial cells on fibronectin even though they play a minor role in adhesion. J Biol Chem. 1994;269:11133-11137.
72. Mould AP, Askari JA, Craig SE, et al. Integrin α4β1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. J Biol Chem. 1994;269:27224-27230.
73. Ly DP, Zazzali KM, Corbett SA. De novo expression of the integrin α5β1 regulates αvβ3-mediated adhesion and migration on fibrinogen. J Biol Chem. 2003;278:21878-21885.
74. Miao H, Li S, Hu YL, et al. Differential regulation of Rho GTPases by β1 and β3 integrins: the role of an extracellular domain of integrin in intracellular signaling. J Cell Sci. 2002;115:2199-2206.
75. Danen EHJ, van Rheenen J, Franken W, et al. Integrins control motile strategy through a Rho-cofilin pathway. J Cell Biol. 2005;169:515-528.
76. Steely HT, Browder SL, Julian MB, et al. The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1992;33:2242-2250.
77. Rodrigues MM, Katz SI, Foidart JM, Spaeth GL. Collagen, factor VIII antigen, and immunoglobulins in the human aqueous drainage channels. Ophthalmology. 1980;87:337-345.
78. Babizhayev MA, Brodskaya MW. Immunohistochemical monitoring of the effect of a synthetic fibronectin-like peptide (Arg-Gly-Asp) on the age-related changes in the isolated human corneoscleral tissue of glaucomatous eyes. Mech Ageing Dev. 1993;72:1-12.
79. Babizhayev MA, Brodskaya MW. Fibronectin detection in drainage outflow system of human eyes in ageing and progression of open-angle glaucoma. Mech Ageing Dev. 1989;47:145-157.
80. Hann CR, Springett MJ, Wang X, Johnson DH. Ultrastructural localization of collagen IV, fibronectin, and laminin in the trabecular meshwork of normal and glaucomatous eyes. Ophthalmic Res. 2001;33:314-324.
81. Dickerson JE Jr, Steely HT Jr, English-Wright SL, Clark AF. The effect of dexamethasone on integrin and laminin expression in cultured human trabecular meshwork cells. Exp Eye Res. 1998;66:731-738.
82. Tian B, Brumback LC, Kaufman PL. ML-7, chelerythrine and phorbol ester increase outflow facility in the monkey eye. Exp Eye Res. 2000;71:551-566.
83. Tian B, Kaufman PL, Volberg T, Gabelt BT, Geiger B. H-7 disrupts the actin cytoskeleton and increases outflow facility. Arch Ophthalmol. 1998;116:633-643.
84. Honjo M, Tanihara H, Inatani M, et al. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and out-flow facility. Invest Ophthalmol Vis Sci. 2001;42:137-144.
85. Vittitow JL, Garg R, Rowlette LL, et al. Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures. Mol Vis. 2002;8:32-44.
86. Rao PV, Deng P, Maddala R, et al. Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis. 2005;11:288-297.
87. Liu X, Hu Y, Filla MS, et al. The effect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis. 2005;11:1112-1121.
88. Gabelt BT, Hu Y, Vittitow JL, et al. Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res. Published online, January 25, 2006.